STRATA Skin Sciences, Inc.
Formerly Mela Sciences, Inc.
STRATA Skin Sciences, Inc. is listed today as Strata Skin Sciences, Inc.: market value, financials and filings are on its company page.
Funding rounds
0 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2018 | $17 M | Private placement after listing | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Strata Skin Sciences, Inc., its revenue in fiscal 2025 came from these business segments: Dermatology Recurring Procedures $21.48 million (70%), Dermatology Procedures Equipment $9.22 million (30%).
Annual report (SEC XBRL) · Dec 2025
STRATA Skin Sciences, Inc. had revenue between $25 million and $100 million when it filed its newest notice of a funding round (Jun 2018).
SEC Form D (revenue range) · Jun 2018
The industry group it chose in its notices: Manufacturing.
SEC Form D · Jun 2018
Products and services#
No products or services of STRATA Skin Sciences, Inc. are on record.
Investors#
2 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Broadfin Capital, LLC | Fund or asset manager | not stated | not stated | Held Series A preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Broadfin Healthcare Master Fund Ltd | Fund or asset manager | not stated | not stated | Held Series A preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Dolev Rafaeli | President & CEO | Jun 2018 |
| Matthew Hill | CFO | Jun 2018 |
| David Gill | Director | Jun 2018 |
| LuAnn Via | Director | Jun 2018 |
| Nachum Shamir | Director | Jun 2018 |
| Samuel Navarro | Director | Jun 2018 |
| Samuel Rubinstein | Director | Jun 2018 |
| Uri Geiger | Chairman of the Board | Jun 2018 |
About
Company in Irvington, United States.
Went public since 2005. Its SEC number is that of a company listed on a stock exchange.